title: Depressive symptoms predict increased incidence of neuropsychiatric side effects in patients treated with efavirenz.
authors.forename: Larry
authors.initials: L
authors.lastname: Boly
authors.forename: Virginia
authors.initials: V
authors.lastname: Cafaro
authors.forename: Toby
authors.initials: T
authors.lastname: Dyner
mesh_terms: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D003863:Depression / Q000150:complications*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D010078:Oxazines / Q000009:adverse effects*; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
chemical_list: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz